Literature DB >> 10023796

Pre- and postnatal lead effect on head circumference: a case for critical periods.

S J Rothenberg1, L Schnaas, E Perroni, R M Hernández, S Martínez, C Hernández.   

Abstract

We examined the association of maternal prenatal [range of median blood lead level 7.5-9.0 microg/dl (0.36-0.43 micromol/l) during pregnancy] and child postnatal blood lead level [range of median blood lead level from birth to 48 months 7.0-10.0 microg/dl (0.34-0.48 micromol/l)] with head circumference in from 119 to 199 children from the Mexico City Prospective Lead Study. We used repeated multiple regression modeling with a standard set of control variables, entering blood lead level last. Using Bonferroni-corrected probability values to control for inflation of Type I error due to multiple testing at each age, we found significant negative associations (p<0.05, two-tailed) between 6-month head circumference and 36-week maternal blood lead level, and 36-month head circumference and 12-month blood lead level. Over the 25-75% interquartile range of measured blood lead, head circumference decreased around 0.4 cm. Over the 1-35 microg/dl (0.05-1.68 micromol/l) range of maternal blood lead at 36 weeks, the estimated reduction in 6-month head circumference was 1.9 cm (95% CI = 0.9-3.0 cm). These results suggest that children are more vulnerable to certain effects of lead exposure at specific age ranges, and that the effect of lead on head circumference only becomes evident for brief periods in the first 4 years of life. We discuss various artifacts as well as possible mechanisms by which lead might have produced the observed pattern of results. We suggest that higher lead exposure prevalent several decades ago might have subtly influenced published normative human growth data.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023796     DOI: 10.1016/s0892-0362(98)00034-8

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  7 in total

1.  Growth in Inuit children exposed to polychlorinated biphenyls and lead during fetal development and childhood.

Authors:  Renée Dallaire; Éric Dewailly; Pierre Ayotte; Nadine Forget-Dubois; Sandra W Jacobson; Joseph L Jacobson; Gina Muckle
Journal:  Environ Res       Date:  2014-07-18       Impact factor: 6.498

2.  Factors influencing the difference between maternal and cord blood lead.

Authors:  E W Harville; I Hertz-Picciotto; M Schramm; M Watt-Morse; K Chantala; J Osterloh; P J Parsons; W Rogan
Journal:  Occup Environ Med       Date:  2005-04       Impact factor: 4.402

3.  Growth of infants' length, weight, head and arm circumferences in relation to low levels of blood lead measured serially.

Authors:  Lawrence M Schell; Melinda Denham; Alice D Stark; Patrick J Parsons; Elaine E Schulte
Journal:  Am J Hum Biol       Date:  2009 Mar-Apr       Impact factor: 1.937

Review 4.  Childhood Lead Exposure and Adult Neurodegenerative Disease.

Authors:  Aaron Reuben
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Recommendations for medical management of adult lead exposure.

Authors:  Michael J Kosnett; Richard P Wedeen; Stephen J Rothenberg; Karen L Hipkins; Barbara L Materna; Brian S Schwartz; Howard Hu; Alan Woolf
Journal:  Environ Health Perspect       Date:  2006-12-22       Impact factor: 9.031

6.  Stunting is associated with blood lead concentration among Bangladeshi children aged 2-3 years.

Authors:  Kelsey M Gleason; Linda Valeri; A H Shankar; Md Omar Sharif Ibne Hasan; Quazi Quamruzzaman; Ema G Rodrigues; David C Christiani; Robert O Wright; David C Bellinger; Maitreyi Mazumdar
Journal:  Environ Health       Date:  2016-11-04       Impact factor: 5.984

Review 7.  Methods to quantify soft tissue-based cranial growth and treatment outcomes in children: a systematic review.

Authors:  Sander Brons; Machteld E van Beusichem; Ewald M Bronkhorst; Jos M Draaisma; Stefaan J Bergé; Jan G Schols; Anne Marie Kuijpers-Jagtman
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.